Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Erythropoietin preconditioning in neuronal cultures: signaling, protection from in vitro ischemia, and proteomic analysis.

Meloni BP, Tilbrook PA, Boulos S, Arthur PG, Knuckey NW.

J Neurosci Res. 2006 Mar;83(4):584-93.

PMID:
16435392
2.

Lyn deficiency reduces GATA-1, EKLF and STAT5, and induces extramedullary stress erythropoiesis.

Ingley E, McCarthy DJ, Pore JR, Sarna MK, Adenan AS, Wright MJ, Erber W, Tilbrook PA, Klinken SP.

Oncogene. 2005 Jan 13;24(3):336-43.

PMID:
15516974
3.

New insights into the regulation of erythroid cells.

Ingley E, Tilbrook PA, Klinken SP.

IUBMB Life. 2004 Apr;56(4):177-84. Review.

4.

HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor.

Lalonde JP, Lim R, Ingley E, Tilbrook PA, Thompson MJ, McCulloch R, Beaumont JG, Wicking C, Eyre HJ, Sutherland GR, Howe K, Solomon E, Williams JH, Klinken SP.

J Biol Chem. 2004 Feb 27;279(9):8181-9. Epub 2003 Dec 8.

5.

Differential regulation of SOCS genes in normal and transformed erythroid cells.

Sarna MK, Ingley E, Busfield SJ, Cull VS, Lepere W, McCarthy DJ, Wright MJ, Palmer GA, Chappell D, Sayer MS, Alexander WS, Hilton DJ, Starr R, Watowich SS, Bittorf T, Klinken SP, Tilbrook PA.

Oncogene. 2003 May 22;22(21):3221-30.

6.

Type I interferon differential therapy for erythroleukemia: specificity of STAT activation.

Cull VS, Tilbrook PA, Bartlett EJ, Brekalo NL, James CM.

Blood. 2003 Apr 1;101(7):2727-35. Epub 2002 Nov 21.

7.

Enforced expression of HOX11 is associated with an immature phenotype in J2E erythroid cells.

Greene WK, Ford J, Dixon D, Tilbrook PA, Watt PM, Klinken SP, Kees UR.

Br J Haematol. 2002 Sep;118(3):909-17.

PMID:
12181065
8.

MADM, a novel adaptor protein that mediates phosphorylation of the 14-3-3 binding site of myeloid leukemia factor 1.

Lim R, Winteringham LN, Williams JH, McCulloch RK, Ingley E, Tiao JY, Lalonde JP, Tsai S, Tilbrook PA, Sun Y, Wu X, Morris SW, Klinken SP.

J Biol Chem. 2002 Oct 25;277(43):40997-1008. Epub 2002 Aug 9.

9.

Erythropoietin-stimulated Raf-1 tyrosine phosphorylation is associated with the tyrosine kinase Lyn in J2E erythroleukemic cells.

Tilbrook PA, Colley SM, McCarthy DJ, Marais R, Klinken SP.

Arch Biochem Biophys. 2001 Dec 1;396(1):128-32.

PMID:
11716471
10.

Thyroid hormone receptor-interacting protein 1 modulates cytokine and nuclear hormone signaling in erythroid cells.

Ingley E, Chappell D, Poon SY, Sarna MK, Beaumont JG, Williams JH, Stillitano JP, Tsai S, Leedman PJ, Tilbrook PA, Klinken SP.

J Biol Chem. 2001 Nov 16;276(46):43428-34. Epub 2001 Sep 5.

11.

Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.

Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull VS, Williams JH, Ingley E, Schneider-Mergener J, Krystal G, Klinken SP.

Cancer Res. 2001 Mar 15;61(6):2453-8.

12.

Ectopic expression of transcription factor NF-E2 alters the phenotype of erythroid and monoblastoid cells.

Sayer MS, Tilbrook PA, Spadaccini A, Ingley E, Sarna MK, Williams JH, Andrews NC, Klinken SP.

J Biol Chem. 2000 Aug 18;275(33):25292-8.

13.

HS1 interacts with Lyn and is critical for erythropoietin-induced differentiation of erythroid cells.

Ingley E, Sarna MK, Beaumont JG, Tilbrook PA, Tsai S, Takemoto Y, Williams JH, Klinken SP.

J Biol Chem. 2000 Mar 17;275(11):7887-93.

14.

Dominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivo.

Cull V, Tilbrook PA, Adenan AS, Chappell D, Ingley E, Sarna MK, Palmer TN, Watowich SS, Klinken SP.

Oncogene. 2000 Feb 17;19(7):953-60.

15.

The erythropoietin receptor.

Tilbrook PA, Klinken SP.

Int J Biochem Cell Biol. 1999 Oct;31(10):1001-5. Review.

PMID:
10582333
16.

HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1.

Williams JH, Daly LN, Ingley E, Beaumont JG, Tilbrook PA, Lalonde JP, Stillitano JP, Klinken SP.

EMBO J. 1999 Oct 15;18(20):5559-66.

17.

A novel ADP-ribosylation like factor (ARL-6), interacts with the protein-conducting channel SEC61beta subunit.

Ingley E, Williams JH, Walker CE, Tsai S, Colley S, Sayer MS, Tilbrook PA, Sarna M, Beaumont JG, Klinken SP.

FEBS Lett. 1999 Oct 1;459(1):69-74.

18.

Erythropoietin and erythropoietin receptor.

Tilbrook PA, Klinken SP.

Growth Factors. 1999;17(1):25-35. Review. No abstract available.

PMID:
10495960
19.
20.
21.

Haemoglobin synthesis in erythropoietin-stimulated J2E cells does not require increased numbers of transferrin receptors.

Callus BA, Busfield SJ, Rossi E, Tilbrook PA, Chappell D, Morgan EH, Klinken SP.

Eur J Biochem. 1997 Dec 1;250(2):459-66.

23.
24.

Lyn tyrosine kinase is essential for erythropoietin-induced differentiation of J2E erythroid cells.

Tilbrook PA, Ingley E, Williams JH, Hibbs ML, Klinken SP.

EMBO J. 1997 Apr 1;16(7):1610-9.

25.

Prevention of apoptosis in J2E erythroid cells by erythropoietin: involvement of JAK2 but not MAP kinases.

Chappell D, Tilbrook PA, Bittorf T, Colley SM, Meyer GT, Klinken SP.

Cell Death Differ. 1997 Feb;4(2):105-13.

26.

Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells.

Tilbrook PA, Bittorf T, Callus BA, Busfield SJ, Ingley E, Klinken SP.

Cell Growth Differ. 1996 Apr;7(4):511-20.

27.

Disrupted signaling in a mutant J2E cell line that shows enhanced viability, but does not proliferate or differentiate, with erythropoietin.

Tilbrook PA, Bittorf T, Busfield SJ, Chappell D, Klinken SP.

J Biol Chem. 1996 Feb 16;271(7):3453-9.

28.

Truncated erythropoietin receptor in a murine erythroleukemia cell line.

Bittorf T, Busfield SJ, Klinken SP, Tilbrook PA.

Int J Biochem Cell Biol. 1996 Feb;28(2):175-81.

PMID:
8729004
29.

Amiloride suppresses erythropoietin-induced proliferation and MAP kinase, but potentiates differentiation of J2E cells.

Callus B, Tilbrook PA, Busfield SJ, Cull VS, Bittorf T, Klinken SP.

Exp Cell Res. 1995 Jul;219(1):39-46.

PMID:
7543055
30.

The major erythroid DNA-binding protein GATA-1 is stimulated by erythropoietin but not by chemical inducers of erythroid differentiation.

Busfield SJ, Spadaccini A, Riches KJ, Tilbrook PA, Klinken SP.

Eur J Biochem. 1995 Jun 1;230(2):475-80.

31.

Erythropoietin exerts transcriptional and translational control over globin synthesis in J2E cells.

Busfield SJ, Chappell DS, Jennings G, Trengove NJ, Riches KJ, Callus BA, Tilbrook PA, Klinken SP.

Cell Growth Differ. 1995 Apr;6(4):429-37.

33.

Post-translational modifications of p21rho proteins.

Adamson P, Marshall CJ, Hall A, Tilbrook PA.

J Biol Chem. 1992 Oct 5;267(28):20033-8.

34.

Detection of papillomaviral-like DNA sequences in premalignant and malignant perineal lesions of sheep.

Tilbrook PA, Sterrett G, Kulski JK.

Vet Microbiol. 1992 Jun 15;31(4):327-41.

PMID:
1323166
35.

Enhancement of u.v.-induced skin carcinogenesis in the hairless mouse by inoculation with cell-free extracts of skin tumours.

Reeve VE, Greenoak GE, Canfield PJ, Boehm-Wilcox C, Tilbrook PA, Kulski JK, Gallagher CH.

Immunol Cell Biol. 1989 Dec;67 ( Pt 6):421-7.

PMID:
2560465
36.

Identification of papillomaviral DNA sequences in hairless mouse tumours induced by ultraviolet irradiation.

Tilbrook PA, Greenoak GE, Reeve VE, Canfield PJ, Gissmann L, Gallagher CH, Kulski JK.

J Gen Virol. 1989 Apr;70 ( Pt 4):1005-9.

PMID:
2543760

Supplemental Content

Loading ...
Support Center